Keywords: enrollment, begins, phase, ii, rhb1, trials, somatogen

Enrollment Begins In Phase II rHB1.1 Trials

Article | 21 November 1994

Print This

Somatogen has begun enrolling patients into two Phase II trials of its recombinant hemoglobin product, rHb1.1, which is intended for ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in